Biosimilars: Theory, Empirics, and Policy Implications
نویسندگان
چکیده
منابع مشابه
Biosimilars: Implications for health-system pharmacists.
PURPOSE An update on scientific and regulatory challenges in the rapidly evolving field of biosimilar product development is presented. SUMMARY The U.S. market for biosimilar products (i.e., highly similar "follow-on" versions of approved biological drugs) is expected to expand with establishment of an expedited-approval pathway for biosimilars similar to that implemented in European Union co...
متن کاملRecitation 7: Empirics and Theory on Monetary Policy Design
Over the last couple of weeks in lectures, we have considered optimal monetary policy in the baseline model and in models with extensions. Professor Gali provided an empirical overview of monetary policy rules in di¤erent periods, for example the US experience preand post-Volcker. In the context of cost-push shocks, we discussed monetary policy with and without commitment. This recitation hando...
متن کاملThe Health Policy Process in Vietnam: Going Beyond Kingdon’s Multiple Streams Theory; Comment on “Shaping the Health Policy Agenda: The Case of Safe Motherhood Policy in Vietnam”
This commentary reflects upon the article along three broad lines. It reflects on the theoretical choices and omissions, particularly highlighting why it is important to adapt the multiple streams framework (MSF) when applying it in a socio-political context like Vietnam’s. The commentary also reflects upon the analytical threads tackled by Ha et al; for instance, it highlights the opportunitie...
متن کاملPatient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
This policy research aims to map patient access barriers to biologic treatments, to explore how increased uptake of biosimilars may lower these hurdles and to identify factors limiting the increased utilisation of biosimilars. A policy survey was developed to review these questions in 10 Central and Eastern European (CEE) and Commonwealth of Independent States (CIS) countries. Two experts (one ...
متن کاملKey drivers for market penetration of biosimilars in Europe
Background & Objectives: Potential drivers and barriers of biosimilar uptake were mainly analysed through qualitative approaches. The study objective was to conduct a quantitative analysis and identify drivers of biosimilar uptake of all available biosimilars in the European Union (EU). Methods: A three-step process was established to identify key drivers for the uptake of biosimilars in the to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014